Bremer Bank National Association Amgen Inc Transaction History

Bremer Bank National Association

$526 Million
Q3 2024

A detailed history of Bremer Bank National Association transactions in Amgen Inc stock. As of the latest transaction made, Bremer Bank National Association holds 12,945 shares of AMGN stock, worth $3.36 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares

12,945

Previous 12,605 2.7%

Holding current value

$3.36 Million

Previous $3.94 Million 5.92%

% of portfolio

0.79%

Previous 0.78%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$309.38 - $337.38 $105,189 - $114,709	340 Added 2.7%	12,945 $4.17 Million
Q2 2024 Jul 16, 2024	SELL	$262.75 - $319.31 $213,878 - $259,918	-814 Reduced 6.07%	12,605 $3.94 Million
Q1 2024 Apr 17, 2024	SELL	$268.87 - $324.56 $1.1 Million - $1.33 Million	-4,089 Reduced 23.36%	13,419 $3.82 Million
Q4 2023 Jan 11, 2024	BUY	$255.7 - $288.46 $340,336 - $383,940	1,331 Added 8.23%	17,508 $5.04 Million
Q3 2023 Oct 20, 2023	BUY	$218.65 - $271.46 $2.32 Million - $2.87 Million	10,589 Added 189.5%	16,177 $4.35 Million
Q2 2023 Jul 17, 2023	SELL	$214.27 - $253.37 $9,856 - $11,655	-46 Reduced 0.82%	5,588 $1.24 Million
Q1 2023 Apr 13, 2023	SELL	$225.79 - $275.2 $39,287 - $47,884	-174 Reduced 3.0%	5,634 $1.36 Million
Q4 2022 Jan 12, 2023	BUY	$229.03 - $291.01 $1.33 Million - $1.69 Million	5,808 New	5,808 $1.53 Million
Q2 2022 Jul 08, 2022	SELL	$230.71 - $256.74 $19,610 - $21,822	-85 Reduced 7.01%	1,128 $274,000
Q1 2022 Apr 07, 2022	BUY	$219.27 - $242.57 $4,385 - $4,851	20 Added 1.68%	1,213 $294,000
Q4 2021 Jan 10, 2022	SELL	$198.88 - $227.6 $2,386 - $2,731	-12 Reduced 1.0%	1,193 $268,000
Q3 2021 Oct 05, 2021	SELL	$212.27 - $248.7 $36,510 - $42,776	-172 Reduced 12.49%	1,205 $256,000
Q2 2021 Jul 13, 2021	SELL	$233.58 - $259.14 $61,898 - $68,672	-265 Reduced 16.14%	1,377 $335,000
Q1 2021 Apr 07, 2021	SELL	$221.91 - $258.6 $66,794 - $77,838	-301 Reduced 15.49%	1,642 $408,000
Q4 2020 Jan 12, 2021	SELL	$216.38 - $257.67 $7,789 - $9,276	-36 Reduced 1.82%	1,943 $447,000
Q3 2020 Oct 22, 2020	SELL	$234.65 - $260.95 $17,129 - $19,049	-73 Reduced 3.56%	1,979 $503,000
Q2 2020 Jul 28, 2020	SELL	$197.81 - $242.74 $51,430 - $63,112	-260 Reduced 11.25%	2,052 $484,000
Q1 2020 Apr 17, 2020	BUY	$182.24 - $241.7 $24,237 - $32,146	133 Added 6.1%	2,312 $469,000
Q4 2019 Jan 27, 2020	SELL	$189.21 - $243.2 $51,654 - $66,393	-273 Reduced 11.13%	2,179 $526,000
Q3 2019 Oct 03, 2019	SELL	$174.11 - $208.62 $41,612 - $49,860	-239 Reduced 8.88%	2,452 $474,000
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $29,839 - $34,978	-179 Reduced 6.24%	2,691 $496,000
Q1 2019 May 09, 2019	BUY	$180.87 - $203.88 $519,096 - $585,135	2,870 New	2,870 $514,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $139B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bremer Bank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Bremer Bank National Association with notifications on news.

Account

Bremer Bank National Association Amgen Inc Transaction History